3 Global Stocks Estimated To Be Trading At A Discount Of Up To 48.6%
As global markets navigate a landscape marked by interest rate adjustments and trade developments, major U.S. stock indexes have reached record highs, buoyed by the Federal Reserve’s recent decision to lower short-term interest rates. Amidst this economic climate, identifying undervalued stocks can be an appealing strategy for investors seeking opportunities; these stocks may offer potential value as market conditions continue to evolve.
Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
Truecaller (OM:TRUE B) |
SEK43.24 |
SEK85.34 |
49.3% |
Rheinmetall (XTRA:RHM) |
€1928.00 |
€3793.66 |
49.2% |
Pansoft (SZSE:300996) |
CN¥17.03 |
CN¥33.77 |
49.6% |
NexTone (TSE:7094) |
¥2249.00 |
¥4456.29 |
49.5% |
Micro Systemation (OM:MSAB B) |
SEK61.40 |
SEK121.94 |
49.6% |
Japan Data Science ConsortiumLtd (TSE:4418) |
¥970.00 |
¥1932.50 |
49.8% |
Guangdong Marubi Biotechnology (SHSE:603983) |
CN¥39.13 |
CN¥77.81 |
49.7% |
Gofore Oyj (HLSE:GOFORE) |
€14.78 |
€29.47 |
49.9% |
Digital Workforce Services Oyj (HLSE:DWF) |
€3.41 |
€6.78 |
49.7% |
ATON Green Storage (BIT:ATON) |
€2.05 |
€4.09 |
49.9% |
We’ll examine a selection from our screener results.
Overview: Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally, with a market cap of ₩8.87 trillion.
Operations: The company’s revenue is derived from biotechnology startups, contributing ₩2.17 billion.
Estimated Discount To Fair Value: 13.7%
Yuhan Corporation’s recent earnings report shows a strong increase in net income, reaching KRW 45.53 billion for Q2 2025, up from KRW 32.06 billion a year ago. The company is trading at ₩123,000, below its estimated fair value of ₩142,492.94 and has initiated a share buyback program to enhance shareholder value. Despite lower profit margins compared to last year and one-off items affecting results, Yuhan’s earnings are expected to grow significantly above market averages over the next three years.
Overview: Alkhorayef Water and Power Technologies Company, with a market cap of SAR4.76 billion, focuses on designing, constructing, operating, maintaining, and managing water and wastewater projects in Saudi Arabia.
Operations: The company’s revenue segments consist of SAR991.60 million from water, SAR1.03 billion from wastewater, and SAR320.92 million from integrated water solutions.
Credit: Source link